children
sever
immunodefici
present
impair
clearanc
respiratori
virus
pulmonari
complic
viral
infect
lead
caus
morbid
mortal
group
howev
role
respiratori
virus
children
type
primari
immunodefici
pid
mainli
humor
immunodefici
hid
diseas
immun
dysregul
hardli
studi
children
hid
usual
suffer
recurr
bacteri
respiratori
infect
result
progress
bronchiectasi
chronic
lung
immunoglobulin
replac
therapi
irt
reduc
frequenc
infect
howev
despit
adequ
irt
recurr
respiratori
infect
still
one
lead
caus
morbid
mortal
littl
data
current
avail
regard
suscept
respiratori
virus
hypogammaglobulinem
patient
receiv
howev
virus
describ
play
signific
role
human
herpesviru
associ
granulomatouslymphocyt
interstiti
lung
diseas
glild
patient
common
variabl
immunodefici
cvid
enteroviru
known
caus
fatal
meningoenceph
patient
agammaglobulinemia
xla
addit
sever
recent
report
show
increas
suscept
viral
respiratori
infect
adult
cvid
receiv
contribut
chronic
persist
pulmonari
report
best
knowledg
first
studi
analys
respiratori
virus
pediatr
patient
predominantli
antibodi
defici
requir
irt
consid
relationship
clinic
symptom
pulmonari
function
bacteri
treatment
outcom
npa
nasopharyng
swab
sent
virolog
investig
influenza
respiratori
virus
laboratori
nation
center
microbiolog
isciii
madrid
spain
sampl
process
within
h
collect
upon
recept
three
aliquot
prepar
store
recept
npa
sampl
process
area
separ
defin
work
area
three
independ
assay
perform
detect
sixteen
respiratori
virus
previous
publish
influenza
b
c
virus
detect
use
previous
describ
primer
set
amplifi
influenza
virus
multiplex
pcr
second
multiplex
pcr
use
detect
parainfluenza
virus
human
coronavirus
enterovirus
rhinovirus
rv
presenc
respiratori
syncity
viru
rsv
b
type
human
metapneumoviru
human
bocaviru
adenovirus
investig
third
multiplex
spontan
sputum
sampl
collect
use
steril
specimen
contain
immedi
process
store
process
feasibl
sampl
cultur
standard
media
potenti
respiratori
tract
pathogen
identifi
test
antimicrobi
suscept
pulmonari
function
test
perform
patient
studi
entri
repeat
everi
sampl
collect
spirometri
perform
accord
establish
use
jaeger
spiromet
viasi
healthcar
gmbh
hoechberg
germani
deriv
particip
use
norm
global
lung
function
initi
gli
base
special
develop
softwar
desktop
softwar
individu
calcul
http
wwwerseducationorgguidelinesgloballungfunctioninitiativespirometrytoolsdesktopindividualcalculatoraspx
gli
sever
classif
base
z
score
employ
mild
moder
moder
sever
sever
sever
episod
posit
viral
detect
n
associ
respiratori
symptom
case
control
regard
respiratori
symptom
viral
posit
case
mild
moderatesever
asymptomat
episod
neg
viral
detect
less
frequent
associ
respiratori
symptom
posit
episod
versu
present
mild
symptom
sever
episod
posit
viral
detect
associ
impair
lung
function
higher
level
antibiot
prescrib
hospit
admiss
tabl
result
suggest
viral
respiratori
tract
infect
may
play
import
role
children
predominantli
antibodi
defici
experi
presenc
respiratori
symptom
neg
bacteri
sputum
cultur
impair
lung
function
antibiot
prescript
hospit
admiss
significantli
associ
viral
detect
author
alreadi
report
respiratori
viral
infect
seem
play
role
adult
studi
report
viral
detect
rate
respiratori
exacerb
rhinoviru
frequent
episod
frequent
symptomat
hid
patient
compar
healthi
observ
howev
role
viral
respiratori
infect
children
hid
hardli
analyz
mechan
increas
suscept
viral
respiratori
infect
patient
well
irt
may
offer
protect
mucos
surfac
iga
igm
replac
immunoglobulin
igm
highli
effect
agglutin
especi
addit
duraisingham
et
al
observ
patient
hid
respiratori
viral
infect
present
lower
level
iga
patient
neg
viral
seri
patient
posit
viral
detect
present
adequ
igg
level
low
iga
level
could
favor
infect
author
also
suggest
antibodi
origin
lymphat
tissu
respiratori
mucosa
may
play
import
role
system
antibodi
pulmonari
sinu
addit
persist
viral
infect
could
result
chronic
antigen
stimul
context
dysregul
immun
system
could
exacerb
inflammatori
studi
bacteri
sputum
cultur
frequent
posit
children
neg
virolog
test
howev
antibiot
prescript
higher
patient
viral
respiratori
infect
import
percentag
patient
posit
viral
episod
associ
respiratori
symptom
result
viral
test
avail
earli
episod
duraisingham
et
al
observ
posit
viral
sampl
studi
obtain
patient
neg
bacteriolog
sperlich
et
al
also
report
virus
commonli
present
adult
cvid
upper
respiratori
tract
symptom
respond
poorli
suggest
antibiot
usag
could
better
target
hand
author
hypothes
persist
recurr
viral
respiratori
infect
could
advers
affect
microbiom
lead
increas
bacteri
densiti
children
nasopharyng
tract
predispos
sinopulmonari
bacteri
recommend
screen
viral
infect
children
hid
acut
respiratori
symptom
avoid
unnecessari
antibiot
treatment
howev
viral
test
routin
perform
children
sever
combin
immunodefici
scid
regard
hid
protocol
present
great
deal
variat
across
europ
manag
lung
urgent
need
consensu
guidelin
monitor
lung
complic
treat
respiratori
infect
hid
patient
typic
hid
xla
cvid
three
case
scid
patient
receiv
hematopoiet
cell
transplant
present
persist
lymphopenia
hypogammaglobulinemia
although
children
scid
recov
cellular
immun
year
transplant
mani
patient
like
irt
consider
period
full
reconstitut
immun
immun
reconstitut
consequ
regard
viral
respiratori
infect
deepli
investig
patient
data
support
patient
also
prone
viral
respiratori
infect
impact
lung
function
lead
antibiot
consumpt
anoth
patient
regard
humor
immun
mani
patient
requir
immunoglobulin
infus
due
memori
lymphopenia
declin
specif
antibodi
recurr
respiratori
tract
infect
describ
children
develop
although
bacteria
detect
respiratori
exacerb
viral
pneumonia
also
lung
sequela
patient
frequent
mainli
thu
monitor
viral
infect
children
may
import
one
patient
seri
suffer
diseas
heterogen
respiratori
infect
complic
frequent
often
spectrum
pathogen
highli
reminisc
primari
antibodi
defici
syndrom
coulter
et
note
signific
adenoviru
infect
occur
cohort
virus
commonli
identifi
respiratori
exacerb
includ
rsv
parainfluenza
echoviru
coxsacki
final
one
patient
pid
develop
persist
lymphopenia
secondari
hypogammaglobulinemia
requir
irt
year
receiv
rituximab
treat
nephrot
syndrom
rituximab
first
monoclon
antibodi
develop
persist
hypogammaglobinemia
use
report
recent
clinic
studi
highlight
patient
may
develop
clinic
condit
similar
cvid
degre
hypogammaglobulinemia
directli
associ
infect
infect
includ
sever
respiratori
tract
infect
remain
common
advers
effect
monoclon
howev
clinic
impact
hypogammaglobulinemia
induc
therapi
remain
unclear
studi
sever
limit
includ
small
number
patient
suffer
differ
type
hid
vari
molecular
mechan
despit
heterogen
case
result
indic
signific
role
viral
respiratori
infect
children
term
clinic
symptom
lung
function
antibiot
prescript
hospit
admiss
also
observ
viral
isol
frequent
associ
symptom
case
compar
healthi
control
although
group
differ
term
age
immun
allow
direct
comparison
studi
ideal
includ
healthi
control
better
assess
impact
viral
infect
children
humor
immunodefici
howev
peltola
et
report
durat
symptom
rhinoviru
shed
longer
adult
hid
healthi
children
reason
expect
respiratori
virus
might
caus
symptom
patient
compar
healthi
children
although
abl
prove
spite
limit
respiratori
viral
infect
seem
play
role
children
hid
also
describ
studi
need
improv
knowledg
impact
respiratori
viral
infect
prevent
manag
children
irt
aim
avoid
consequ
author
declar
conflict
interest
